ITMCTR2200005624尚未招募1 期
Randomized, double-blind, placebo-controlled, multicenter clinical study on acupoint application in the treatment of postherpetic neuralgia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 —（—）
- 性别
- All
入选标准
- •1.In line with the diagnostic criteria of postherpetic neuralgia ; 2.
- •2. VAS = 4 points ;
- •3. Age 18-75 years ;
- •4. Course of disease > 30 days, = 180 days
- •5. Patients and their families sign informed consent.
排除标准
- •1. Patients with liver and kidney failure ;
- •2. For those studying drug allergy ;
- •3. Persons with coagulation disorders ;
- •4. Persons with cognitive impairment who cannot cooperate ;
- •5. pregnant or lactating women with mental and nervous system diseases ;
- •6. Always taking other analgesics.
研究者
相似试验
进行中（未招募）
1 期
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis (non-CF BE)bronchiectasisMedDRA version: 14.1Level: PTClassification code 10006445Term: BronchiectasisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004208-39-ESBayer HealthCare AG300
进行中（未招募）
1 期
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis (non–CF BE)non-CF bronchiectasisMedDRA version: 19.0Level: PTClassification code 10006445Term: BronchiectasisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-004659-19-DEBayer AG492
进行中（未招募）
不适用
Randomized, double-blind, placebo-controlled, multi-centre, multi-national study to evaluate the efficacy and safety of oral BAY 63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg tid) in patients with symptomatic Pulmonary Arterial Hypertension (PAH). - PATENT-1 StudyPulmonary Arterial Hypertension (PAH)MedDRA version: 9.1Level: LLTClassification code 10064911Term: Pulmonary arterial hypertensionEUCTR2008-003482-68-DKBayer HealthCare AG, D-51368 Leverkusen462
进行中（未招募）
1 期
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis (non–CF BE)bronchiectasisEUCTR2011-004208-39-ITBAYER HEALTHCARE AG300
进行中（未招募）
2 期
Study of efficacy and safety of NaPPS in patients with knee osteoarthritisknee osteoarthritisJPRN-jRCT2071210131Matsumoto Tadashi90